Document is current
Any future updates will be listed below
-
Authors
Ghazi Vakili, Mohammad
Gorgulla, Christoph https://orcid.org/0000-0001-6986-5270
Snider, Jamie
Nigam, AkshatKumar
Bezrukov, Dmitry
Varoli, Daniel
Aliper, Alex
Polykovsky, Daniil https://orcid.org/0000-0002-0899-8368
Padmanabha Das, Krishna M.
Cox III, Huel
Lyakisheva, Anna
Hosseini Mansob, Ardalan https://orcid.org/0009-0005-4651-5362
Yao, Zhong
Bitar, Lela
Tahoulas, Danielle https://orcid.org/0009-0007-7542-1802
Čerina, Dora https://orcid.org/0000-0002-1116-0136
Radchenko, Eugene https://orcid.org/0000-0002-2091-7022
Ding, Xiao
Liu, Jinxin
Meng, Fanye
Ren, Feng https://orcid.org/0000-0001-9157-9182
Cao, Yudong
Stagljar, Igor https://orcid.org/0000-0002-5260-3327
Aspuru-Guzik, Alán https://orcid.org/0000-0002-8277-4434
Zhavoronkov, Alex https://orcid.org/0000-0001-7067-8966
-
Funding
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-23-3-0017, HR0011-23-3-0017)
Gouvernement du Canada | Natural Resources Canada
Canada First Research Excellence Fund
Anders G. Froseth for his generous support
SU | Stanford Bio-X
Gouvernement du Canada | Canadian Institutes of Health Research
Ontario Research Foundation
Genome Canada
Cystic Fibrosis Canada
Ontario Genomics Institute
Toronto Innovation Acceleration Partners
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 6 December 2024
First Online: 22 January 2025
Competing interests
: A.A.G. serves as the chief visionary officer and is a board member of Kebotix. A.Z., A.A., D.B., D.P., X.D., J.L., E.R., F.R. and F.M. are affiliated with Insilico Medicine. Y.C. and D.V. are affiliated with Zapata AI. C.G. is a cofounder and consultant of Virtual Discovery and Quantum Therapeutics. The remaining authors declare no competing interests.
